BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2956062)

  • 1. Correlation of plasma beta-endorphin levels with mean arterial pressure and cardiac output in hypovolemic shock.
    Daly T; Beamer KC; Vargish T; Wilson A
    Crit Care Med; 1987 Aug; 15(8):723-5. PubMed ID: 2956062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of methylprednisolone on naloxone's hemodynamic response in canine hypovolemic shock.
    Beamer KC; Vargish T
    Crit Care Med; 1986 Feb; 14(2):115-9. PubMed ID: 3943316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late administration of methylprednisolone does not enhance naloxone effect in hypovolemic shock.
    Beamer KC; Daly T; Vargish T
    Circ Shock; 1986; 19(2):221-30. PubMed ID: 3719922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of naloxone in early canine hypovolemic shock.
    Vargish T; Beamer K
    Circ Shock; 1985; 17(1):45-57. PubMed ID: 2996802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Endorphin in canine hemorrhagic shock.
    Tuggle DW; Horton JW
    Surg Gynecol Obstet; 1986 Aug; 163(2):137-44. PubMed ID: 3016926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endorphins in primate hemorrhagic shock: beneficial action of opiate antagonists.
    McIntosh TK; Palter M; Grasberger R; Vezina R; Gerstein L; Yeston N; Egdahl RH
    J Surg Res; 1986 Mar; 40(3):265-75. PubMed ID: 2936929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine and cardiovascular changes in septic shock and after cardiac surgery: effect of high-dose corticosteroid therapy.
    Hinds CJ; Evans SF; Varley JG; Tomlin S; Rees LH
    Circ Shock; 1985; 15(1):61-72. PubMed ID: 2983903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating dopamine levels and a protective action of naloxone in canine splanchnic arterial occlusion shock.
    Eddy LJ; Joiner DW; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):113-25. PubMed ID: 6701397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic changes following corticosteroid and naloxone infusion in dogs subjected to hypovolemic shock without resuscitation.
    Vargish T; Gurll NJ; Reynolds DG; Lutz SA; Ganes EM
    Life Sci; 1983 Aug; 33(5):489-93. PubMed ID: 6877033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of temperature on naloxone treatment in canine hemorrhagic shock.
    Horton JW; Tuggle DW; Kiser RS
    Circ Shock; 1984; 14(4):251-65. PubMed ID: 6096039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma beta-endorphin immunoreactivity in dogs during anesthesia, surgery, Escherichia coli sepsis, and naloxone therapy.
    Rees M; Bowen JC; Payne JG; MacPhee AA
    Surgery; 1983 Mar; 93(3):386-90. PubMed ID: 6298964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone therapy of human septic shock.
    Bonnet F; Bilaine J; Lhoste F; Mankikian B; Kerdelhue B; Rapin M
    Crit Care Med; 1985 Nov; 13(11):972-5. PubMed ID: 2932301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone reversal of hypovolemic shock in dogs.
    Vargish T; Reynolds DG; Gurll NJ; Lechner RB; Holaday JW; Faden AI
    Circ Shock; 1980; 7(1):31-8. PubMed ID: 6248264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiocirculatory effects of physiological doses of beta-endorphin.
    Tuggle DW; Horton JW
    Circ Shock; 1986; 18(3):215-25. PubMed ID: 2938843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of blood levels of beta-endorphin-like immunoreactivity in patients with shock.
    Pasi A; Moccetti T; Legler M; Mueller J; Foletta D; Gramsch C; Hartmann H
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):509-12. PubMed ID: 6320322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone requires circulating catecholamines to attenuate the cardiovascular suppression of endotoxic shock.
    Allgood SC; Gurll NJ; Reynolds DG
    J Surg Res; 1988 Jan; 44(1):73-81. PubMed ID: 3336212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic evaluation of ibuprofen in canine hypovolemic shock.
    Beamer KC; Daly T; Vargish T
    Circ Shock; 1987; 23(1):51-7. PubMed ID: 3690813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone in treatment of circulatory shock resistant to conventional therapy.
    Allolio B; Fischer H; Kaulen D; Deuss U; Winkelmann W
    Klin Wochenschr; 1987 Mar; 65(5):213-7. PubMed ID: 3033394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endorphins and vasopressin in canine endotoxin shock.
    Cronenwett JL; Baver-Neff BS; Grekin RJ; Sheagren JN
    J Surg Res; 1986 Dec; 41(6):609-19. PubMed ID: 2946895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.